Abstract
In recent years, vitreous humour, a connective tissue at the centre of the eye, emerged as a preferred reservoir for back of the eye drug delivery. Although vitreous humour is largely composed of water (>99%), its physical form can range from a firm gel in the youth to a collapsed gel in the elderly. These changes in the physical form of the vitreous, in conjunction with changes in its composition and turnover, can potentially influence drug delivery to target tissues from the vitreous. In order to enable the reader with the development of personalised medicines for the back of the eye, this chapter discusses vitreal anatomy, convective flow patterns, barriers to drug delivery, drug clearance mechanisms, and the influence of vitrectomy and vitreous substitutes on drug delivery. Further, it presents case studies on interactions of drug delivery systems with vitreous gel as well as the influence of eye movements on drug delivery from the vitreous. Wherever feasible, the above parameters were compared between normal and ageing eyes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acar N, Kapran Z, Unver YB et al (2008) Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions. Retina 28(4):545–552
Ahmadieh H, Feghhi M, Tabatabaei H et al (2008) Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy. A randomized clinical trial. Ophthalmology 115:1938–1943
Akiba J, Ueno N, Chakrabarti B (1994) Mechanisms of photo-induced vitreous liquefaction. Curr Eye Res 13:505–512
Akiba J, Kakehashi A, Ueno N et al (1995) Serum-induced collagen gel contraction. Graefes Arch Clin Exp Ophthalmol 233:430–434
Antcliff RJ, Spalton DJ, Stanford MR et al (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study historical image. Ophthalmology 108(4):765–772
Araie M, Maurice DM (1991) The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. Exp Eye Res 52(1):27–39
Araiz JJ, Refojo MF, Arroyo MH et al (1993) Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretionopathy. Invest Ophthalmol Vis Sci 34:522–530
Ashton P (2006) Retinal drug delivery. In: Jaffe GJ, Ashton P, Pearson PA (eds) Intraocular drug delivery. Taylor and Francis, New York, p 17
Atluri H, Mitra AK (2003) Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis. Exp Eye Res 76:315–320
Atluri H, Anand BS, Patel J et al (2003) Mechanism of a model dipeptide transport across blood ocular barriers following systemic administration. Invest Phthalmol Vis Sci 44(5): Abstract 364
Atluri H, Talluri RS, Mitra AK et al (2008) Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of l-phenyl alanine. Int J Pharm 34712:23–30
Aukunuru J, Sunkara G, Bandi N et al (2001) Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm Res 18:565–572
Bakri SJ, Snyder MR, Reid JM et al (2007) Pharmacokinetics of intravitreal bevacizumab (avastin). Ophthalmology 114:855–859
Balazs EA, Denlinger JL (1982) Aging changes in the vitreous. In: Sekular R, Kline D, Dismukes K (eds) Aging and human visual function. AR Liss, New York, pp 45–57
Balazs L (1960) Physiology of the vitreous body. In: Schepens CL (ed) Vitreous body in retina surgery: special emphasis on reoperations. CV Mosby, St. Louis, pp 29–48
Balazs EA, Denlinger JL (1984) The vitreous. In: Daveson H (ed) The eye. Academic, New York, pp 533–589
Barza M, Kane A, Baum J (1983) Pharmacokinetics of intravitreal carbenicillin, cefazolin and gentamicin in rhesus monkeys. Invest Ophthalmol Vis Sci 24:1602–1606
Beer PM, Bakri SJ, Singh RJ et al (2003) Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110:681–686
Benz MS, Albini TA, Holz ER et al (2006) Ophthalmology 113:1174–1178
Bettelheim FA, Samuel Zigler Jr J (2004) Regional mapping of molecular components of human liquid vitreous by dynamic light scattering. Exp Eye Res 79:713–718
Bishop P (2000) Structural macromolecules and supramolecular organization of the vitreous gel. Prog Retin Eye Res 19(3):323–344
Bito LZ (1977) The physiology and pathophysiology of intraocular fluids. Exp Eye Res 25(Suppl):273–289
Bito LZ, Baroody RA (1987) Ocular trace metal kinetics and toxicology. I. The distribution of intravitreally injected Cu++ within intraocular compartments and its loss from the globe. Invest Ophthalmol Vis Sci 28:101–105
Boon CJF, Klevering BJ, Kuijk FJ et al (2008) Reflux after intravitreal injection of bevacizumab. Ophthalmology 115(7):1268–1269
Brasnjevic IH, Steinbusch WH, Schmitz C et al (2009) Delivery of peptide and protein drugs over the blood-brain barrier. Prog Neurobiol 87(4):212–251
Brown DJ, Bishop P, Hamdi H, Kenney MC (1996) Cleavage of structural components of mammalian vitreous by endogeneous matrix metalloproteinase-2. Curr Eye Res 15(4):439–445
Chastain JE (2003) Chapter 3: general considerations in ocular drug delivery. In: Mitra AK (ed) Ophthalmic drug delivery system, vol 130. Marcel Dekker, New York, pp 83–90
Ciferri A, Magnasco A (2007) The vitreous gel: a composite structured network engineered by nature. Liq Cryst 34(2):219–227
Cobo LM, Forster RK (1981) The clearance of intravitreal gentamicin. Am J Ophthalmol 92:59–62
Constable PA, Lawrenson JG, Dolman DEM et al (2006) P-Glycoprotein expression in human retinal pigment epithelium cell lines. Exp Eye Res 83(1):24–30
Cunha-Vaz JG (1997) The blood-ocular barriers: past, present and future. Doc Ophthalmol 93:149–157
Cussler EL (2009) Diffusion: mass transfer in fluid systems. Cambridge University Press, Cambridge
Dalkara D, Kolstad KD, Caporale N et al (2009) Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther 17:2096–2102
De Juan E, Hardy M, Hatchell DL et al (1986) The effect of intraocular silicone oil on anterior chamber oxygen pressure in cats. Arch Ophthalmol 104:1063–1064
Dhillon B, Kamal A, Leen C (1998) Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS. Int J STD AIDS 9(4):227–230
Dias CS, Mitra AK (2000) Vitreal elimination kinetics of large molecular weight FITC-labeled dextrans in albino rabbits using a novel microsampling technique. Pharm Sci 89:572–578
Duke-Elder WS (1930) The nature of the vitreous body, Monograph supplement IV. Br J Ophthalmol. Monograph supplement V: 44
Dvorhik BH, Marquis JK (2000) Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit. Drug Metab Dispos 28:1255–1261
Falavarjani KG, Modarres M, Nazari H (2010) Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy. Eye 24:717–719
Falkner CI, Binder S, Kruger A (2001) Outcome after silicone oil removal. Br J Ophthalmol 85:1324–1327
Fatt I (1975) Flow and diffusion in the vitreous body of the eye. Bull Math Biol 37:85–90
Fatt I (1977) Hydraulic flow conductivity of the vitreous. Invest Ophthalmol Vis Sci 16:565–568
Ficker L, Meredith TA, Gardner S et al (1990) Cefazolin levels after intravitreal injection. Invest Ophthalmol Vis Sci 31(3):502–505
Foulds WS, Allan D, Moseley H et al (1985) Effect of intravitreal hyaluronidase on the clearance of tritiated water from the vitreous to the choroid. Br J Ophthalmol 69:529–532
Fowlkes WL (1963) Meridonal flow from the corona ciliaris through the pararetinal zone in the rabbit vitreous. Invest Ophthalmol Vis Sci 2(1):63–71
Friedrich S, Cheng Y, Saville B (1997a) Drug distribution in the vitreous humour of the human eye: the effects of intravitreal injection position and volume. Curr Eye Res 16:663–669
Friedrich S, Cheng Y, Saville B (1997b) Finite element modelling of drug distribution in the vitreous humor of the rabbit eye. Ann Biomed Eng 25:303–314
Gardner TW, Antonetti DA, Barber AJ et al (2000) The molecular structure and function of the inner blood-retinal barrier. Doc Ophthalmol 97:229–237
Gauthier R, Joly S, Pernet V et al (2005) Brain-derived neurotrophic factor gene delivery to mueller glia preserves structure and function of light-damaged photoreceptors. Invest Ophthalmol Vis Sci 46:3383–3392
Giordano GG, Refojo MF (1998) Silicone oils as vitreous substitutes. Prog Polym Sci 23:509–532
Gisladottir S, Loftsson T, Stefansson E (2009) Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation. Graefes Arch Clin Exp Ophthalmol 247:1677–1684
Guembel HOC, Krieglsteiner S, Rosenkranz C et al (1999) Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis. Graefes Arch Clin Exp Ophthalmol 237:824–829
Halfter W (1998) Disruption of the retinal basal lamina during early embryonic development leads to a retraction of vitreal endfeet, and increased number of ganglion cells, and aberrant axon outgrowth. J Comp Neurol 397:89–104
Halfter W, Dong S, Schurer B et al (2005) Embryonic synthesis of the inner limiting membrane and vitreous body. Invest Ophthalmol Vis Sci 46:2202–2209
Han Y, Sweet DH, Hu D et al (2001) Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. J Pharmacol Exp Ther 296:450–457
Hardwig PW, Pulido JS, Bakri SJ (2008) The safety of intraocular methotrexate in silicone-filled eyes. Retina 28:1082–1086
Heiduschka P, Fietz PH, Hofmeister S et al (2007) Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48:2814–2823
Hennessy M, Spiers JP (2007) A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol Res 55(1):1–15
Hertz L, Dienel GA (2004) Lactate transport and transporters: general principles and functional roles in brain cells. J Neurosci Res 79(1–2):11–18
Holekamp NM (2010) The vitreous gel: more than meets the eye. Am J Ophthalmol 149:32–36
Hornan D, Edmeades N, Krishnan R et al (2010) Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy. Eye (Lond). doi:10.1038/eye.2010.14
Hosoya K, Kondo T, Tomi M et al (2001) MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina. Pharm Res 18:1670–1676
Hosoya K, Ohshima Y, Katayama K et al (2003) Use of microdialysis to evaluate efflux transport of organic anions across the blood-retinal barrier. AAPS PharmSci 5(S1):583
Hosoya K, Makihara A, Tsujikawa Y et al (2009a) Roles of inner blood-retina barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin and 6-mercaptopurine. J Pharm Exp Ther 329:87–93
Hosoya K, Tachikawa M et al (2009b) Inner blood-retinal barrier transporters: role of retinal drug delivery. Pharm Res 26:2055–2065
Itakura H, Kishi S, Kotajima N et al (2009) Decreased vitreal hyaluronan levels with aging. Ophthalmologica 223:32–35
Jongebloed WL, Worst JFG (1987) The cisternal anatomy of the vitreous body. Doc Ophthalmol 67:183–196
Jonas JB, Halyer JK, Panda-Jonas S (2000) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 84:1064–1067
Kakeshi A, Ueno N, Chakrabarti B (1994) Molecular mechanisms of photochemically induced posterior vitreous detachment. Ophthalmic Res 26:51–59
Kathawate J, Acharya S (2008) Computational modeling of intravitreal drug delivery in the vitreous chamber with different vitreous substitutes. Int J Heat Mass Transfer 51(23–24):5598–5609
Kagemann L, Wollstein G, Ishikawa H et al (2006) Persistence of Cloquet’s Canal in normal healthy eyes. Am J Ophthalmol 142:862–864
Kim H, Lizak MJ, Tansey G et al (2005) Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging. Ann Biomed Eng 33(2):150–164
Kim H, Csaky KG, Chan C et al (2006) The pharmacokinetics of rituximab following an intravitreal injection. Exp Eye Res 82(5):760–766
Kitano S, Nagataki S (1986) Transport of fluorescein monoglucuronide out of the vitreous. Invest Ophthalmol Vis Sci 27:998–1001
Koeberle MJ, Hughes PM, Skellern GG et al (2003) Binding of memantine to melanin: influence of type of melanin and characteristics. Pharm Res 20(10):1702–1709
Kolancy D, Pars-Vanginderdueren R, Van Lommel A, Stalmans P (2005) Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema. Bull Soc Belge Ophthalmol 296:15–23
Konstantinidis L, Mameletzi E, Mantel I et al (2009) Intravitreal ranibizumab (Lucentis) in the treatment of retina angiomatous proliferation (RAP). Graefes Arch Clin Ophthalmol 247(9):1165–1171
Kralinger MR, Kieselbach GF, Voigt M et al (2001a) Slow release of acetylsalicylic acid by intravitreal silicone oil. Retina 21:513–520
Kralinger MT, Hamasaki D, Kieselbach GF et al (2001b) Intravitreal acetylsalicylic acid in silicone oil: pharmacokinetics and evaluation of its safety by ERG and histology. Graefes Arch Clin Exp Ophthalmol 239:208–216
Krohne TU, Eter N, Holz FG et al (2008) Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol 146(4):508–512
Kunimoto DY, Kaiser RS, Wills Eye Retina Service (2007) Incidence of endophthalmitis after 20-and 25-gauge vitrectomy. Ophthalmology 114:2133–2137
Kusuhara H, Sugiyama Y (2004) Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv Drug Deliv Rev 56(12):1741–1763
Lai MM, Ruby AJ, Sarrafizadeh R et al (2008) Repair of primary rhegmatogeneous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy. Retina 28(5):729–734
Laude A, Tan LE, Wilson CG et al (2010) Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res 29(6):466–475
Lee SS, Harutyunyan I, D’Argenio DZ et al (2009) The effect of vitreous syneresis on drug transport. In: Proceedings: ARVO summer eye research conference, NIH, Bethesda. Abstract no 8, p 17
Mannermaa E, Vellonen K-S, Urtti A et al (2006) Drug transport in corneal epithelium and blood-retina barrier: Emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58(11):1136–1163
Maurice DM (1957) The exchange of sodium between the vitreous body and the blood and aqueous humor. J Physiol 137:110–125
Maurice DM (1987) Flow of water between aqueous and vitreous compartments in the rabbit eye. Am J Physiol 252:F104–F108
Maurice DM (1997) The regurgitation of large vitreous injections. J Ocul Pharmacol Ther 13(5):461–463
McLeod D (1986) Silicone-oil injection during closed microsurgery for diabetic retinal detachment. Graefes Arch Clin Exp Ophthalmol 224:55–59
Missel P (2002) Hydraulic flow and vascular clearance influences on intravitreal drug delivery. Pharm Res 19(11):1636–1647
Missel P, Homer M, Muralikrishnan R (2010) Simulating dissolution of intravitreal triamcinolone acetonide suspensions in an anatomically accurate rabbit eye model. Pharm Res 27:1530–1546
Modarres M, Nazari H, Falavarjani KG et al (2009) Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 19(5):848–852
Moldow B, Sander B, Larsen M et al (1998) The effect of acetazolamide passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefes Arch Clin Exp Ophthalmol 236:881–889
Mortlet N, Young SH (1993) Prevention of intraocular pressure rise following intravitreal injection. Br J Ophthalmol 77:572–573
Moseley H (1981) Mathematical model of diffusion in the vitreous humour of the eye. Clin Phys Physiol Meas 2(3):175–181
Moseley H, Foulds WS, Allan D et al (1984) Routes of clearance of radioactive water from the rabbit vitreous. Br J Ophthalmol 68:145–151
Mura M, Tan SH, Smet MD (2009) Use of 25-gauge vitrectomy in the management of primary rhegmatogeneous retinal detachment. Retina 29:1299–1304
Nakagawa M, Refojo MF, Marin JF et al (1995) Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretionopathy. Invest Ophthalmol Vis Sci 36:2388–2395
Nakin KN, Lavin MJ, Leaver PK (1992) Primary vitrectomy for rhegmatogeneous retinal detachment. Graefes Arch Clin Exp Ophthalmol 231:344–346
Okamoto F, Okamoto Y, Fukada S et al (2010) Vision-related quality of life and visual function after vitrectomy for various vitreoretinal disorders. Invest Opthalmol 51:744–751
Park J, Bungay PM, Lutz RJ et al (2005) Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. J Control Release 105(3):279–295
Park KH, Woo SJ, Hwang JM et al (2010) Short-term outcome of bimanual 23-gauge transconjunctival sutureless vitrectomy for patients with complicated vitreoretinopathies. Ophthalmic Surg Lasers Imaging 41(2):207–214
Parravano M, Oddone F, Tedeschi M et al (2010) Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results. Retina 30(7):1017–1024
Pastor JC, Nozal MJD, Zamarron E et al (2008) Solubility of triamcinolone acetonide and other anti-inflammatory drugs in silicone oil. Implications for therapeutic efficacy. Retina 28:1247–1250
Peeters L, Sanders N, Braeckmans K et al (2005) Vitreous: a barrier to nonviral ocular gene therapy. Invest Ophthalmol Vis Sci 46:3553–3561
Perkins SL, Yang CH, Ashton P et al (2001) Pharmacokinetics of the ganciclovir implant in the silicone-filled eye. Retina 21:10–14
Pitkänen L, Ruponen M, Nieminen J (2003) Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm Res 20(4):576–583
Pitkänen L, Ranta V, Moilanen H et al (2005) Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci 46:641–646
Poliner LS, Schoch LH (1987) Intraocular pressure assessment in gas-filled eyes following vitrectomy. Arch Ophthalmol 105(2):200–202
Rajan PD, Kekuda R, Chancy CD et al (2000) Expression of the extraneuronal monoamine transporter in RPE and neural retina. Curr Eye Res 20:195–204
Richards AJ, Baguley DM, Yates JRW et al (2000) Variation in the vitreous phenotype of stickler syndrome can be caused by different amino acid substitutions in the X position of the type ii collagen gly-X-Y triple helix. Am J Hum Genet 67:1083–1094
Ruby AJ, Grand MG, William D et al (1999) Intraoperative acetazolamide in the prevention of intraocular pressure rise after pars plana vitrectomy with fluid-gas exchange. Retina 19(3):185–187
Sakurai E, Ozeki H, Kunou N et al (2001) Effect of particle size of polymeric nanospheres on intravitreal kinetics. Ophthalmic Res 33:31–36
Scholes GN, O’Brien WJ, Abrams G et al (1985) Clearance of triamcinolone from vitreous. Arch Ophthalmol 103:1567–1569
Sebag J (1987) Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 225:89–93
Sebag J (1989) The vitreous. Springer, New York
Sebag J (1998) Macromolecular structure of the corpus vitreous. Prog Polym Sci 23:415–446
Sebag J (2005) Molecular biology of pharmacology vitreolysis. Trans Am Opthalmol Soc 103:473–494
Sebag J, Balazs EA (1989) Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 30:1867–1871
Shen J, Cross ST, Tang-Liu D et al (2003) Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal-barrier. Pharm Res 20:1357–1363
Shimada H, Nakashizuka H, Hattori T et al (2008) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Causes and prevention. Ophthalmology 115:2215–2220
Shimada H, Hattori T, Nakashizuka H et al (2009) Highly viscous fluid in macular holes. Case report. Int Ophthalmol. doi:10.007/s10792-009-9321-z
Singh A, Stewart JM (2008) Intraocular bevacizumab for iris neovascularization in a silicone oil-filled eye. Retinal Cases Brief Reports 2:253–255
Smith RJH (1981) Rubeotic glaucoma. Br J Ophthalmol 65:606–609
Spielberg L, Leys A (2009) Intravitreal bevacizumab for hyopic choroidal neovascularization: short-term and 1-year results. Bull Soc Belge Ophthalmol 312:17–27
Spitzer MS, Kaczmarek RT, Yoeruek E et al (2009) The distribution, release kinetics and biocompatibility of triamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci 50:2337–2343
Stay MS, Xu J, Randolph TW et al (2003) Computer simulation of convective and diffusive transport of controlled release drugs in the vitreous humor. Pharm Res 20:96–102
Stefánsson E (2009) Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 247:147–163
Stepanova LV, Marchenko IY, Sychev GM (2005) Direction of fluid transport in the lens [Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny]. Bull Exp Biol Med 139(1):57–58
Steuer H, Jaworski A, Elger B et al (2005) Functional characterization and comparison of the outer blood-retinal barrier. Invest Ophthalmol Vis Sci 46:1047–1053
Stocchino A, Repetto R, Siggers JH (2010) Mixing processes in the vitreous chamber induced by eye rotations. Phys Med Biol 55:453–467
Takahashi J, Hikichi T, Mori F et al (2004) Effect of nucleotide P2Y2 receptor agonists on outward active transport of fluorescein across normal blood-retina barrier in rabbit. Exp Eye Res 78(1):103–108
Tan LE, Orilla W, Tsai S et al (2011) Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran and fluorescent microparticles. Invest Opthalmol Vis Sci 52(2):1111–1118
Thompson JT, Glaser BM (1984) Effect of lensectomy on the movement of tracers from vitreous to aqueous. Arch Ophthalmol 102:1077–1078
Thomas AV, Gilbert SJ, Duance VC (2000) Elevated levels of proteolytic enzymes in the aging human vitreous. Invest Ophthalmol Vis Sci 41(11):3299–3304
Tiedel KG, Gabel VP, Neubaer L et al (1990) Intravitreal silicone oil injection: complications and treatment of 415 consecutive patients. Graefes Arch Clin Exp Ophthalmol 228:19–23
Tognetto D, Minutola D, Sanguinetti G et al (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment. A pilot study. Ophthalmology 112:1574–1578
Tojo K, Nakagawa K, Morita Y et al (1999) A pharmacokinetic model of intravitreal delivery of ganciclovir. Eur J Pharm Biopharm 47(2):99–104
Tsuji A (2005) Influx transporters and drug targeting: application of peptide and cation transporters. Int Congress Series 1277:75–84
Ueno N, Sebag J, Hirokawa H et al (1987) Effects of visible-light irradiation on vitreous structure in the presence of a photosensitizer. Exp Eye Res 44:863–870
Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Del Rev 58:1131–1135
Wolter JR (1964) Pores in the inner limiting membrane of the human retina. Acta Ophthalmol 42:971–974
Worst JGF, Los LI (1995) Chapter 3: functional anatomy of the vitreous. In: Cisternal anatomy of the vitreous. Kugler Publications, Amsterdam, Netherlands, pp 33–48
Xu J, Heys JJ, Barocas VH et al (2000) Permeability and diffusion in the vitreous humor: implications for drug delivery. Pharm Res 17:664–669
Yoganathan P, Deramo VA, Lai JC et al (2006) Visual improvement following intravitreal bevacizumab (avastin) in exudative age-related macular degeneration. Retina 26:994–998
Yoneyama D, Shinozaki Y, Lu WL et al (2010) Involvement of system A in the retina-to-blood transport of l-proline across the inner blood-retinal barrier. Exp Eye Res 90(4):507–513
Young S, Larkin G, Branley M et al (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 29(1):2–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Wilson, C.G., Tan, L.E., Mains, J. (2011). Principles of Retinal Drug Delivery from Within the Vitreous. In: Kompella, U., Edelhauser, H. (eds) Drug Product Development for the Back of the Eye. AAPS Advances in the Pharmaceutical Sciences Series, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9920-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9920-7_6
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-9919-1
Online ISBN: 978-1-4419-9920-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)